Greenland Mines Ltd. Common Stock (GRML)

• Market cap: $44.3M
• 1 day: -12.37%
• 5 days: -10.67%
• 1 month: 85.65%
• 3 months: 8.06%
• 6 months: -29.96%
• Year to date: 28.36%
• 1 year: 46.46%
• 5 years: -95.85%
• 10 years: -95.85%
• Sector: Healthcare
• Industry: Biotechnology

About: Greenland Mines Ltd operates in two divisions: (1) Natural Resources, focused on the exploration and development of the Skaergaard Project in Southeast Greenland, an undeveloped palladium, gold, and platinum deposit; and 2) Cell and Gene Therapy, which focuses on the development of biologic, cell, and gene therapies for neurodegenerative and age-related disorders, including Alzheimer's, amyotrophic lateral sclerosis (ALS), Parkinson's, and related conditions, targeting areas of high unmet medical need.